欧洲 · 交易所与实时行情 · Euronext
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
Novo said a 2.4 milligram dose of CagriSema was associated with an average weight loss of 25% after 68 weeks in 2,309 women enrolled in a late-stage study called REDEFINE 1,…
在 Euronext 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (live.euronext.com)
